Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study

Research Question: Does treatment with tocilizumab increase the risk of a fungal infection in critically ill patients with coronavirus-19? Background: Numerous therapies have been evaluated as possible treatments for coronavirus-2019 caused by severe acute respiratory syndrome coronavirus-2. Tociliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Burger, Barrett J., Epps, Sarenthia M., Cardenas, Victor M., Jagana, Rajani, Meena, Nikhil K., Atchley, William T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455962/
https://www.ncbi.nlm.nih.gov/pubmed/37629609
http://dx.doi.org/10.3390/life13081752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455962/
https://www.ncbi.nlm.nih.gov/pubmed/37629609
http://dx.doi.org/10.3390/life13081752

Ejemplares similares